BTT-3033
{[allProObj[0].p_purity_real_show]}
货号：A1154444
BTT-3033 是一种口服活性、构象选择性的 α2β1 抑制剂（EC50: 130 nM），可结合 α2I 结构域。BTT-3033 抑制血小板与 I 型胶原的结合和细胞增殖，并诱导凋亡。BTT-3033 可用于前列腺癌、炎症和心血管疾病的研究。
BTT-3033 化学结构
CAS号：1259028-99-3
BTT-3033 3D分子结构
CAS号：1259028-99-3
| 规格 |
价格 |
会员价
|
库存 |
数量 |
| {[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
|
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
|
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]}
{[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}
|
现货 |
咨询
|
-
+
|
BTT-3033 纯度/质量文件 产品仅供科研
货号：A1154444
标准纯度：
{[allProObj[0].p_purity_real_show]}
-
全球学术期刊中引用的产品
- • Cell Host Microbe, 2024. Ambeed.
[
A163338
]
- • Cancer Res., 2024. Ambeed.
[
A295334
]
- • J. Pharm. Investig., 2024. Ambeed.
[
A221527 ,
A691302 ,
A272538 ,
A187261
]
- • J. Fungi, 2024, 10(11): 751. Ambeed.
[
A796919
]
- • JBC, 2024, 107935. Ambeed.
[
A194396
]
- 更多 >
BTT-3033 质控信息
| Desvenlafaxine |
++
|
|
|
|
|
|
|
|
98% |
| Lamotrigine |
+
5-HT (rat brain synaptosomes), IC50: 474 μM
5-HT (human platelets), IC50: 240 μM
|
|
|
|
|
|
|
|
98% |
| Venlafaxine |
✔
|
|
|
|
|
|
|
|
98% |
| Fluvoxamine maleate |
✔
|
|
|
|
|
|
|
|
99% |
| Iloperidone |
✔
|
|
|
|
|
|
|
|
98% |
| Ziprasidone HCl |
✔
|
|
|
|
|
|
|
|
98+% |
| Atomoxetine HCI |
+
|
|
|
|
|
|
|
|
98% |
| Dapoxetine HCl |
✔
|
|
|
|
|
|
|
|
97% |
| Trazodone |
✔
|
|
|
|
|
|
|
|
98+% |
| Clomipramine HCl |
✔
|
|
|
|
|
|
|
|
98% |
| Mirtazapine |
✔
|
|
|
|
|
|
|
|
99+% |
| Escitalopram oxalate |
+++
|
|
|
|
|
|
|
|
97% |
| Duloxetine |
✔
|
|
|
|
|
|
|
|
98+% |
| Sertraline HCl |
++
|
|
|
|
|
|
|
|
98% |
| Citalopram HBr |
+++
serotonin reuptake, IC50: 1.8 nM
|
|
|
|
|
|
|
|
98% |
| Latrepirdine 2HCl |
✔
|
|
|
|
|
|
|
GluR
|
98% |
| Fluoxetine HCl |
✔
|
|
|
|
|
|
|
|
99.5% |
| Paroxetine hydrochloride |
✔
|
|
|
|
|
|
|
AChR
|
97% |
| BMY 7378 |
|
++
5-HT1A, pIC50: 6.4
5-HT1D, pIC50: 5.9
|
+
|
|
|
|
|
|
97% |
| Flibanserin |
|
+++
|
+
|
|
|
|
|
|
98% |
| LY310762 |
|
+
|
|
|
|
|
|
|
99%+ |
| Cyclobenzaprine HCI |
|
|
✔
|
|
|
|
|
|
99% |
| Blonanserin |
|
|
+++
|
|
|
|
|
|
98% HPLC |
| Cyproheptadine HCl |
|
|
++++
|
|
|
|
|
|
99+% |
| Olanzapine |
|
|
✔
|
|
|
|
|
|
99+% |
| Pimavanserin hemitartrate |
|
|
+++
|
|
|
|
|
|
99% |
| Ketanserin |
|
|
+++
5-HT2C (Rat), Ki: 50 nM
5-HT2C (Human), Ki: 2.5 nM
|
|
|
|
|
|
99%+ |
| Loxapine succinate |
|
|
++
5-HT2 (human), Ki: 6.8 nM
5-HT2 (bovine), Ki: 6.6 nM
|
|
|
|
|
|
99% |
| Agomelatine |
|
|
✔
|
|
|
|
|
|
98% |
| Clozapine |
|
|
✔
|
|
|
|
|
|
98% |
| Amitriptyline |
|
|
+
|
|
|
|
|
SERT
|
98% |
| PRX-08066 maleate |
|
|
+++
|
|
|
|
|
|
98+% |
| RS-127445 |
|
|
++++
5-HT2B, pIC50: 10.4
5-HT2B, pKi: 9.5
|
|
|
|
|
|
99%+ |
| Sarpogrelate HCl |
|
|
++++
5-HT2C, Kd: 1.1 nM
5-HT2A, Kd: 2.1 nM
|
|
|
|
|
|
98% |
| Tropisetron |
|
|
|
✔
|
|
|
|
|
99% |
| Palonosetron |
|
|
|
✔
|
|
|
|
|
98+% |
| Ramosetron HCl |
|
|
|
++++
5-HT3 receptor, Ki: 0.091 nM
|
|
|
|
|
98% |
| Ondansetron |
|
|
|
✔
|
|
|
|
|
99% |
| Granisetron |
|
|
|
✔
|
|
|
|
|
98% |
| Alosetron HCl |
|
|
|
✔
|
|
|
|
|
98% |
| Ondansetron hydrochloride dihydrate |
|
|
|
✔
|
|
|
|
|
98% |
| VUF10166 |
|
|
|
++++
5-HT3A, Ki: 0.04 nM
5-HT3AB, Ki: 22 nM
|
|
|
|
|
99%+ |
| Azasetron hydrochloride |
|
|
|
++++
|
|
|
|
|
98% |
| Asenapine maleate |
|
+++
5-HT1A, pKi: 8.6
5-HT1B, pKi: 8.4
|
++++
5-HT2A, pKi: 9.75
5-HT2C, pKi: 10.46
|
|
+++
|
++++
|
++++
|
|
97% |
| Risperidone |
|
++
5-HT1B, Ki: 14.9 nM
5-HT1D, Ki: 84.6 nM
|
++++
5-HT2A, Ki: 61.9 nM
5-HT2C, Ki: 12 nM
|
|
+
|
|
++
|
|
98% |
| SB 271046 HCl |
|
|
|
|
|
+++
|
|
|
99%+ |
| Intepirdine |
|
|
|
|
|
++++
|
|
|
99%+ |
| SB-269970 HCl |
|
|
|
|
|
|
++
|
|
98+% |
| BRL 15572 |
|
++
5-HT1D, pKi: 6
5-HT1B, pKi: 6.1
|
++
5-HT2B, pKi: 6.2
5-HT2A, pKi: 6.6
|
|
|
+
|
+
|
|
98% |
|
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。
|
BTT-3033 实验方案
| 计算器 |
|
| 存储液制备 |
 |
1mg |
5mg |
10mg |
|
1 mM
5 mM
10 mM
|
2.15mL
0.43mL
0.21mL
|
10.74mL
2.15mL
1.07mL
|
21.48mL
4.30mL
2.15mL
|
BTT-3033 技术信息
搜索
